PMV Pharmaceuticals, Inc. (PMVP)
1.27
-0.04
(-2.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Price to Book Value : 0.9496 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.9496 |
| October 22, 2026 | 0.9757 |
| October 21, 2026 | 1.017 |
| October 20, 2026 | 1.039 |
| October 19, 2026 | 0.9384 |
| October 16, 2026 | 0.9047 |
| October 15, 2026 | 0.9645 |
| October 14, 2026 | 0.9271 |
| October 13, 2026 | 1.009 |
| October 12, 2026 | 1.054 |
| October 09, 2026 | 1.136 |
| October 08, 2026 | 1.114 |
| October 07, 2026 | 1.122 |
| October 06, 2026 | 1.204 |
| October 05, 2026 | 1.331 |
| October 02, 2026 | 1.338 |
| October 01, 2026 | 1.308 |
| September 30, 2026 | 1.249 |
| September 29, 2026 | 1.069 |
| September 28, 2026 | 1.017 |
| September 25, 2026 | 0.9944 |
| September 24, 2026 | 0.9982 |
| September 23, 2026 | 1.024 |
| September 22, 2026 | 1.129 |
| September 21, 2026 | 1.103 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.122 |
| September 17, 2026 | 1.092 |
| September 16, 2026 | 1.069 |
| September 15, 2026 | 1.017 |
| September 14, 2026 | 1.092 |
| September 11, 2026 | 1.047 |
| September 10, 2026 | 1.077 |
| September 09, 2026 | 1.028 |
| September 08, 2026 | 1.002 |
| September 04, 2026 | 0.9645 |
| September 03, 2026 | 0.9271 |
| September 02, 2026 | 0.9421 |
| September 01, 2026 | 0.9645 |
| August 31, 2026 | 0.9047 |
| August 28, 2026 | 0.9122 |
| August 27, 2026 | 0.9271 |
| August 26, 2026 | 0.9795 |
| August 25, 2026 | 0.9757 |
| August 24, 2026 | 0.9757 |
| August 21, 2026 | 0.9944 |
| August 20, 2026 | 0.972 |
| August 19, 2026 | 0.9571 |
| August 18, 2026 | 0.9271 |
| August 17, 2026 | 0.9346 |
| August 14, 2026 | 0.9421 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 1.27 |
| Earnings Yield | -111.3% |
| Market Cap | 67.89M |